Beyfortus 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FT822
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,608
Award facts
- Contract value 100% obligated
- $17,607.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,607.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Beyfortus 100 mg/ml syringes on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitive, non-set-aside contract was issued to the vendor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. Beyfortus is a respiratory syncytial virus (RSV) immunization product used to provide passive immunity protection in infants and young children, supporting the military's medical supply chain requirements.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, with an extensive portfolio of competitive federal contract awards through the DLA Medical Supply Chain. The company's SPE2DX prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling delivery of a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This specific delivery order for Beyfortus syringes reflects the company's continued role in fulfilling specialized pharmaceutical requirements for the Department of Defense healthcare systems, including the Defense Health Agency and associated military medical facilities.
Quick answers
Who was awarded contract SPE2DR26FT822?
SPE2DR26FT822 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FT822 worth?
The government has obligated $17,608 on SPE2DR26FT822.
Is contract SPE2DR26FT822 an order under another contract?
Yes. SPE2DR26FT822 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT822 competed?
The extent of competition for SPE2DR26FT822 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award